Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELID1P1 (PRELID1 pseudogene 1) is a non-coding pseudogene related to the PRELID1 gene, which encodes a mitochondrial lipid transport protein involved in phosphatidic acid transfer and mitochondrial function[1][2][4]. Unlike its parent gene PRELID1, PRELID1P1 does not produce a functional protein and is not directly involved in cellular processes. Pseudogenes such as PRELID1P1 originate through gene duplication or retrotransposition events and typically lack protein-coding potential; while some pseudogenes have regulatory functions at the RNA level, there is no evidence that PRELID1P1 exerts such effects[3][5]. Note: The functional properties, disease associations, and therapeutic relevance described for PRELID1 (PRELI domain containing 1) do not apply to PRELID1P1, which is non-coding and non-functional. PRELID1P1 should not be used as a molecular target in biomedical research or therapeutic development.
None. PRELID1P1 does not encode a protein and therefore has no mechanisms of drug action associated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELID1 pseudogene 1 (PRELID1P1).